2002
DOI: 10.1078/0344-0338-00198
|View full text |Cite
|
Sign up to set email alerts
|

Clear Cell Carcinoma Arising in Endometriosis of the Rectum Following Progestin Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
1

Year Published

2004
2004
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 10 publications
0
6
0
1
Order By: Relevance
“…Currently, there is no evidence from clinical trials to show a reduced risk of malignant transformation associated with the addition of progestins. Indeed there are case reports where progression of disease is associated with progestin HRT when used without estrogen (12). On balance, combined preparations are preferred in cases with residual endometriosis, severe endometriosis, and obese patients (10).…”
Section: Discussionmentioning
confidence: 98%
“…Currently, there is no evidence from clinical trials to show a reduced risk of malignant transformation associated with the addition of progestins. Indeed there are case reports where progression of disease is associated with progestin HRT when used without estrogen (12). On balance, combined preparations are preferred in cases with residual endometriosis, severe endometriosis, and obese patients (10).…”
Section: Discussionmentioning
confidence: 98%
“…To date, 29 cases of epithelial carcinomas arising in the gastrointestinal endometriosis have been reported in the English-language literature (Tab. I) (4567, 101112, 14, 18192021222324252627). Twenty-five of 29 cases (86.2%) were endometrioid adenocarcinoma, followed by 3 cases of clear cell adenocarcinoma (10.3%).…”
Section: Discussionmentioning
confidence: 99%
“…L'adjonction de progestatifs aux estrogènes serait ainsi, pour ces auteurs, indiquée dans ces cas. À l'inverse, Pokieser et al ont rapporté le cas unique d'une tumeur à cellules claires se développant à partir de lésions d'endométriose après un traitement par médroxyprogestérone seule pendant deux ans, et ce, sans estrogènes associés [26]. Il pose ainsi le problème de l'intérêt des progestatifs dans la prévention de la transformation maligne des endométrioses.…”
Section: Discussionunclassified